Company intelligence / Profile preview

Orphanion

Basel, Switzerland

Ownership: Private
Development stage: Other

Overview

Orphanion is a Swiss CRO/CMO specializing in customized development and procurement services for small to mid-sized biotech and pharma companies, focusing on the production of difficult-to-synthesize molecules for niche applications, including orphan drugs and therapeutic oligonucleotides.

Therapeutic areas: OtherRare Diseases
Industry: Contract Research Organization

Partnerships

LGM Pharma

Beyond the preview

Go deeper on Orphanion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orphanion.

Explore the full profile